TY - JOUR TI - Extramedullary leukemia relapse after allogeneic stem cell transplantation: A novel mechanism of immune escape? AU - Gkirkas, K. AU - Stamouli, M. AU - Karagiannidou, A. AU - Chondropoulos, S. AU - Tsirigotis, P. JO - Journal of Immunotherapy PY - 2020 VL - 12 TODO - 9 SP - 635-640 PB - Future Medicine Ltd SN - 1524-9557 TODO - 10.2217/imt-2019-0215 TODO - azacitidine; cyclosporine; cytarabine; fludarabine; granulocyte colony stimulating factor; HLA antigen; idarubicin; nivolumab; sorafenib, acute graft versus host disease; acute lymphoblastic leukemia; acute myeloid leukemia; adult; allogeneic stem cell transplantation; antigen expression; Article; cancer regression; donor; donor lymphocyte infusion; down regulation; female; haploidentical transplantation; haplotype; HLA matching; human; leukemia cell; leukemia relapse; major clinical study; male; middle aged; mortality; myelodysplastic syndrome; priority journal; treatment outcome; tumor escape; tumor microenvironment; allograft; graft versus host reaction; immunology; leukemia; procedures; recurrent disease; stem cell transplantation, Adult; Allografts; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Recurrence; Stem Cell Transplantation; Treatment Outcome TODO - Background: Relapse is a significant cause of treatment failure after allogeneic stem cell transplantation. In many cases relapse occurs when leukemic cells escape from immune surveillance. Methods &results: In the setting of haploidentical transplantation, immune escape is usually the result of the loss of the mismatched haplotype from leukemic cells, while downregulation of HLA-expression has been postulated as a significant cause of immune escape after transplantation with the use of HLA-matched donors. We observed that patients with acute leukemia who relapse at the time of active graft-versus-host-disease, usually develop extramedullary leukemia while they remain free of leukemia in peripheral blood and bone marrow. Conclusion: Our observation points toward a novel mechanism of immune escape which is microenvironment-specific. © 2020 Future Medicine Ltd. ER -